Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy Subjects
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This study is aimed to study the pharmacokinetic characteristics(e.g. AUC, Cmax, Tmax) of
Ypeginterferon alfa-2a and interferon biomarkers(e.g. 2,5-OAS, neopterin) after single dose
at different levels.